New Delhi, July 21 (IANS) The Research for Resurgence Foundation (RFRF), an RSS-backed academic research organisation, has recommended mapping of industrial sector activities to protect the livelihoods of workers in the wake of a possible third wave of the Covid-19 pandemic.The report titled 'Covid-19 Third Wave and Beyond: Action Plan for Preparedness' was submitted to Union Health Minister Mansukh Mandaviya and the Group of Ministers (GoM) for Covid. Nagpur-based RFRF is the academic research wing of RSS' Bharatiya Shikshan Mandal. The Director General of RFRF, Rajesh Biniwale, said, "Steps should be taken to ensure the livelihoods of the workers in the unorganised sectors during the possible third wave of the pandemic."Biniwale said that the RFRF has also recommended that an awareness programme for reducing mass migration of labourers may be prepared by the local administrations along with the concerned industries."Mix of strategies of continued activity with Covid protocols and financial support may be adopted. The RFRF also suggested that the tax benefits should be extended to the industries so as to support the economy of the workers," Biniwale said.Mukul Kanitakar, national organising secretary, Bharatiya Shikshan Mandal, said that recommendations on 11 different aspects such as health, vaccination, AYUSH integration, predictive modelling, economic issues, sustainability aspects and possible safety through disinfection devices have been included in the report.Kanitakar stated that the report has been prepared by an independent think-tank. "The report is being disseminated among the policy makers, academicians and other stakeholders for its possible effective implementation," he said.For improving the response to health challenges, the report recommended early identification and notification of post-Covid health complications, updating epidemiology based on prevailing data on age, sex, socio-economic patterns etc."Integration of AYUSH with allopathy treatment must be done for improved immunity and post-Covid health management/recovery. Research activities to be supported on priority for medical equipment and devices by creating safe zones by deactivating the virus in ambient/surfaces, comfortable PPEs, safe handling of medical waste (such as used masks) generated in every household, creation of more laboratories for sequencing of RNA, rapid and alternative testing methods ect," the report recommended.For the education sector, the report recommended that different strategies for online/offline classes for primary, secondary and higher education may be prepared. "Use of mass communication media such as TV channels should be promoted for primary and secondary education. For higher education, guideline documents suggesting possibilities of online courses may be prepared by the UGC and the AICTE," the report recommended.--IANSssb/arm
New Delhi, July 5 (IANS) The Supreme Court on Monday stepped-in as counsels for yoga guru Ramdev and doctors' body had heated argument, on former's plea seeking a stay on proceedings in connection with multiple FIRs lodged over his alleged remarks against the use of allopathic medicines during the COVID pandemic.A bench comprising Chief Justice N.V. Ramana, justices A.S. Bopanna and Hrishikesh Roy noted that the court had received material connected with the case at around 11 p.m. on Sunday night. "We got bulky files having copies of statements and videos", said the bench.The apex court was scheduled to examine on Monday, the original records of Ramdev's statement on the use of allopathic medicine following his plea to stay investigation and transfer the cases against him to Delhi.Senior advocate Mukul Rohatgi, appearing for Ramdev, requested the bench to hear the matter on Friday. Senior advocate Rajiv Dutta, appearing for Delhi Medical Association (DMA), which has filed an impleadment application in the matter submitted that his client has created a chart citing all statements made by Ramdev. DMA has called Ramdev a "businessman" clad as a "yoga guru" and claimed that he does not have any degree or license to practice Ayurveda and prescribe medicines.The bench said: "we are not doing anything. We are posting it for next week." Senior advocate P.S. Patwalia, representing the Indian Medical Association and one of the respondents in the matter, submitted that his client has also filed all extracts of Ramdev's statement in its application.At this juncture of the hearing, Rohatgi opposed the application, and said, "They have no role in filing all this". Dutta rebutted, "Don't say, we have no role. What you are stating (in the petition) is all false". The bench intervened, "Don't quarrel". The bench said it may take up the matter on July 12.Ramdev alleged that the IMA has unleashed barrage of cases, civil and criminal, against him via its different chapters in the country.On June 30, Rohatgi had submitted that FIRs have been filed in different parts of the country against his client, and urged the court to club these FIRs, and have a single case in Delhi. He added that his client had launched Coronil for Covid last year, and all the doctors went against him.The bench had asked Rohatgi, "what is the original thing that you spoke?" He had responded, "I will file original video and transcript". After hearing arguments, the top court had scheduled the matter for further hearing on July 12.In the plea, Ramdev sought transfer of FIRs lodged by IMA in Patna and Raipur to Delhi. He has been booked under Sections 188 (disobedience to order duly promulgated by public servant), 269 (negligent act likely to transmit infection of disease dangerous to life), 504 (intentional insult with intent to provoke breach of peace) of the IPC and other provisions of Disaster Management Act, 2005.The voluntary body of doctors accused him of spreading false information in connection with the Allopathic treatment for Covid patients. On May 23, Ramdev had withdrawn his statements on Allopathic medicine after receiving a strong-worded letter from Union Health Minister Harsh Vardhan, who termed his remarks as "inappropriate".--IANSss/skp/
Washington, June 30 (IANS) Covaxin's Covid-19 jab, developed and manufactured by Hyderabad-based Bharat Biotech, generates antibodies that can effectively neutralise the Alpha (B117) and Delta (B1617) variants of SARS-CoV-2, the virus causing Covid-19, the US National Institutes of Health has said citing results from two studies of blood serum from people who received the shots.Covaxin comprises a disabled form of SARS-CoV-2 that cannot replicate but still stimulates the immune system to make antibodies against the virus.The NIH said an adjuvant, developed by the agency, has also contributed to the success of the highly efficacious Covaxin Covid-19 vaccine, which roughly 25 million people have received to date in India and elsewhere.Adjuvants are substances formulated as part of a vaccine to boost immune responses and enhance a vaccine's effectiveness."Ending a global pandemic requires a global response," said Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), part of NIH."I am pleased that a novel vaccine adjuvant developed in the United States with NIAID support is part of an efficacious Covid-19 vaccine available to people in India," he added.The adjuvant used in Covaxin -- Alhydroxiquim-II -- was discovered and tested in the laboratory by the biotech company ViroVax LLC of Lawrence, Kansas with support exclusively from the NIAID Adjuvant Development Programme.The adjuvant comprises a small molecule attached in a unique way to Alhydrogel, a substance frequently called alum that is the most commonly used adjuvant in vaccines for people.Alhydroxiquim-II travels to lymph nodes, where the small molecule detaches from alum and activates two cellular receptors. These receptors, TLR7 and TLR8, play a vital role in the immune response to viruses. Alhydroxiquim-II is the first adjuvant in an authorised vaccine against an infectious disease to activate TLR7 and TLR8.Molecules that activate TLR receptors stimulate the immune system powerfully, but the side effects of Alhydroxiquim-II are mild. This is because, after Covaxin is injected, the adjuvant travels directly to nearby lymph nodes, which contain white blood cells that play an essential role in identifying pathogens and fighting infection.Results from a Phase 2 trial of Covaxin indicate that it is safe and well tolerated, while unpublished interim results from the Phase 3 trial indicate that the vaccine has 78 per cent efficacy against symptomatic disease, 100 per cent efficacy against severe Covid-19, including hospitalisation, and 70 per cent efficacy against asymptomatic infection with SARS-CoV-2.Bharat Biotech signed a licensing agreement with ViroVax to use Alhydroxiquim-II in their candidate vaccines in 2019. This license was expanded during the Covid-19 pandemic to include Covaxin, which has received Emergency Use Authorization in India and more than a dozen other countries.Bharat Biotech developed Covaxin in collaboration with the Indian Council of Medical Research-National Institute of Virology. Bharat Biotech expects to produce an estimated 700 million doses of Covaxin by the end of 2021.--IANSrvt/dpb
Protein is one of the most crucial nutrients required for the healthy functioning of our bodies. The role of protein is commonly misunderstood and is usually associated with muscle gain. Protein has multiple benefits, ranging from metabolism to muscle synthesis. This building block of our body should be an essential part of our diet and should be considered in order to lead a healthier lifestyle.
We all have different protein requirements based on our lifestyles and health factors. For example, a regular, active gym-goer would require more protein per day than your average sedentary man. Pallav Bihani, founder of Boldfit, speaks to IANSlife sharing major symptoms of protein deficiency:
You Can't Seem To Lose The Fat
Have you been working out relentlessly, eating clean and still not seeing a visible difference in your fat loss journey? You need protein. When you don't consume enough protein, your body cannot repair the muscles properly, which eventually leads to the loss of those hard-earned muscles instead of burning fat. Low protein intake can also dip your energy levels marginally, so make sure you are loaded up!
Low protein intake is also linked with unstable moods, irritability and brain fog. Protein is crucial for synthesising a variety of hormones and neurotransmitters responsible for our mood. Such as serotonin, the hormone which makes one feel safe and happy. Missing out on protein can therefore cause fluctuations in one's mood.
Our body requires specific nutrients to be up and running whenever we need to hustle. When you provide inadequate protein, it causes your blood sugar levels to drop, which causes your body to trigger cravings for a quick fix. Consume protein-rich foods to make sure that your blood sugar levels are stable.
Calcium is essential for skeletal integrity, but did you know that 50 per cent of our bones are protein in terms of volume. Along with vitamin D and Calcium, dietary protein is crucial for bone health and longevity. Protein plays a huge role in preserving bone density with ageing.
Skin, Hair and Nail Problems
Your skin, hair and nails are primarily made of protein, and so naturally, a deficiency in protein would reflect on them too. Severe protein deficiency may even cause redness, flaky skin and depigmentation. It may also cause hair thinning, fading, hair loss and brittle nails. Edema, which leads to puffy and swollen skin, is another classic symptom of protein deficiencies.
A safe thumb rule is to consume 1-1.5 grams of protein per kg of bodyweight (i.e.If you weigh 60 kgs, your ideal protein intake goal is between 60 and 90 grams per day). Consume protein from natural sources like meat, eggs, fish, dairy, legumes, soy, and if you cannot meet your goal intake, then invest in protein supplements like whey protein, vegan protein powder and BCAAs.
Read More► Vitamin-Rich Superfoods to Aid Reduce Anxiety, Stress
New Delhi, June 18 (IANS) The Trained Nurses' Association of India (TNAI) has appealed to the Delhi government to recruit only those people who have completed their nursing training, instead of Class XII pass out, for the specialised jobs, in view of the possible third wave of Covid pandemic.The association said there are many unemployed nurses in Delhi and therefore it is suggested to give appointment only to the nursing personnel with proper salary and working conditions. TNAI in a letter to Chief Minister Arvind Kejriwal on Friday has opposed the Delhi government's recently proposed plan to provide training to youth as Community Nursing to strengthen manpower in hospitals in the wake of possible third wave of the pandemic."You cannot expect an 18-year-old, just a Class 12 pass out selected on 'first come-first served' basis to perform such skilled tasks as administering medicines, injections, vaccination, sample collection and catheterisation after just two weeks training. In fact we may play havoc with the people's health if such perfunctory trained persons are asked to do specialised jobs," said TNAI.The association further said that Delhi-NCR is alone a home to 33 colleges and schools of nursing rating BSc Nursing (600), GNM Nurses (600) and ANM (200) and around 1,500 nurses passing every year. Recently, passed out students from these nursing institutions are being equipped properly to perform their tasks.The letter further read, "We kindly request and direct officers to withdraw this proposal immediately. Also we condemn the use of the term 'Nursing' courses which is not approved by the India Nursing Council or the Sate Nursing Council." Earlier, Kejriwal on Wedenesday announced that the Delhi government will provide training to 5,000 youth, who will be working under the direction of doctors and nurses as health assistants in view of a possible third wave of Covid-19. They will be called Community Nursing assistants.Kejriwal also added that these community nursing assistants will be trained in basic nursing, paramedic, lifesaving, first aid and home care, sample collection, oxygen concentrators and cylinder operations, among other things.--IANSpd/sdr/
Chennai, June 17 (IANS) The Tamil Nadu State Construction Labourers welfare board is all set to fund the vaccination drive of the labourers across the state.The welfare board has a cash surplus of Rs 3,000 crores which is collected as one per cent cess levied from project sites across the state. It is to be noted that around 12.13 lakh workers are registered with the Labour welfare board of Tamil Nadu which is half of the total labour population of the state.It may be noted that several studies have revealed that construction workers are one of the most vulnerable groups to be infected with Covid-19 virus and that the group comprises labourers drawn from Bihar, Chattisgarh, Odisha, West Bengal, Rajasthan, Uttar Pradesh and Madhya Pradesh.A senior officer with the labour department told IANS that the department has already placed an order for 2 lakh doses of Covid-19 vaccines with the Tamil Nadu State Medical Service Corporation.Labour department officials told IANS that a group of 100 to 150 labourers will be vaccinated in one site and this would be carried out across the state.According to the labour department sources, they had earlier conducted a vaccination drive with the Greater Chennai Corporation as the construction workers were considered vulnerable and were given priority vaccination. Sources indicated that around 3,500 construction labourers were vaccinated during the drive-in association with the Greater Chennai Corporation.With the reduced supply of vaccines, the camps which were opened in Chennai and other cities of the state started closing down. Industries and workers associations have made representations with the labour department and suggested that the money with the labour welfare board be utilized for this vaccination drive.The department is now speeding up the vaccination drive among the workers and labourers in Tamil Nadu before the North Indian work force returns to the state. CREDAI officials said that they are into awareness campaign among the labourers to take the jab and how it would prevent them being infected by the virus.--IANSaal/dpb
Dear Patron, Please provide additional information to validate your profile and continue to participate in engagement activities and purchase medicine.